A new regulatory framework aimed at strengthening and streamlining the system of pharmacovigilance in the EU will apply from July 2012. To facilitate the implementation of new activities for pharmacovigilance, the European Medicines Agency has established, in collaboration with the competent authorities of Member States, guidelines on good pharmacovigilance practices that are subject to public consultation since 22nd February.
More information on the EMA website.
Contact : vig@afmps.be